BPC-157
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. It’s most often discussed in the context of recovery, where it’s studied for its apparent role in repairing connective tissue and the gut lining.
Most of the evidence to date comes from animal models. Human clinical data is limited, and BPC-157 is not approved by any major regulator for therapeutic use. It is frequently stacked with TB-500 in recovery-focused protocols.
How it works
In preclinical studies, BPC-157 appears to promote angiogenesis — the formation of new blood vessels — which may support tissue repair by improving blood flow to injured areas. It has also been shown to influence growth-factor pathways involved in tendon and ligament healing.
Researchers have also reported effects on the gut-brain axis and on the nitric-oxide system. The precise mechanism in humans is not established.
Reported benefits
- Faster recovery from tendon, ligament, and muscle injuries (animal data)
- Support for gut lining and digestive comfort
- Reduced inflammation at sites of injury
These are reported effects, not guaranteed outcomes.
Considerations & side effects
Because human trials are lacking, the long-term safety profile of BPC-157 is not well characterized. Reported side effects are generally mild and include injection-site irritation, occasional lightheadedness, and nausea.
Product purity varies widely in the research-chemical market. It is not a substitute for evaluation and treatment by a qualified clinician.
Frequently asked
What is BPC-157?
A synthetic 15-amino-acid peptide derived from a protein in gastric juice, studied primarily in animals for tissue repair and gut health.
Is BPC-157 FDA-approved?
No. BPC-157 is not approved by the FDA or any major regulator for human therapeutic use, and is sold for research purposes only.
How is BPC-157 typically administered?
Most commonly by subcutaneous or intramuscular injection after reconstitution with bacteriostatic water.
Does it need to be refrigerated?
Lyophilized (dry) vials are stable at room temperature or refrigerated. Once reconstituted, keep refrigerated and use within about 28 days.
References
Related compounds
An arginate-salt formulation of the BPC-157 pentadecapeptide (also sold as 'PDA'). The arginine salt buffers the peptide across a wider pH range, improving stability and oral bioavailability versus the standard acetate form. Same healing uses as BPC-157.
Pre-mixed blend of BPC-157 and TB-500, the most popular healing combination. Sold as a single combined vial from compounding pharmacies for injury recovery and tissue repair.
Four-peptide regenerative blend combining GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg). Advanced healing and anti-inflammatory protocol. Sold as a single 80mg pre-mixed vial.